Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Vaccines

Free Subscription 15.11.2021 1 AIDS 2 Ann Intern Med 3 BMJ 9 Clin Infect Dis 1 J Immunol 1 J Infect 2 J Infect Dis 4 JAMA 5 Lancet 3 MMWR Morb Mortal Wkly Rep 6 N Engl J Med 1 Pediatrics 7 PLoS One 16 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. MOHAPI L, Pinedo Y, Osiyemi O, Supparatpinyo K, et al
   Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study.
   AIDS. 2021 Nov 8. pii: 00002030-900000000-96271.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. SARPATWARI A, Pandya A, Hyle EP, Persad G, et al
   COVID-19 Vaccine Boosters for All Adults: An Optimal U.S. Approach?
   Ann Intern Med. 2021 Nov 9. doi: 10.7326/M21-3927.
   PubMed        
   
   
3. DELANEY SW, Essien UR, Navathe A
   Disparate Impact: How Colorblind Policies Exacerbate Black-White Health Inequities.
   Ann Intern Med. 2021;174:1450-1451.
   PubMed        
   
   

   
   BMJ

4. TANNE JH
   Covid-19: Biden administration sets 4 January deadline to vaccinate most US workers.
   BMJ. 2021;375:n2708.
   PubMed        
   
   
5. TORJESEN I
   HPV vaccine cut cervical cancer rates in England by 87.
   BMJ. 2021;375:n2689.
   PubMed        
   
   
6. IACOBUCCI G
   Covid-19: How is the UK's vaccine booster programme faring?
   BMJ. 2021;375:n2702.
   PubMed        
   
   

   
   Clin Infect Dis

7. KANSAGRA K, Parmar D, Mendiratta SK, Patel J, et al
   A Phase 3, Randomised, Open-Label, Non-inferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG).
   Clin Infect Dis. 2020 Jun 17. pii: 5858415. doi: 10.1093.
   PubMed         Abstract available
   
   
8. LEE JH, Lee YB, Cho EJ, Yu SJ, et al
   Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study.
   Clin Infect Dis. 2021;73:e3308-e3316.
   PubMed         Abstract available
   
   
9. TESSIER E, Campbell H, Ribeiro S, Fry NK, et al
   Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014-2018.
   Clin Infect Dis. 2021;73:e2502-e2508.
   PubMed         Abstract available
   
   
10. HUANG H, Xu C, Liu L, Chen L, et al
    Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus.
    Clin Infect Dis. 2020 Jul 8. pii: 5868509. doi: 10.1093.
    PubMed         Abstract available
    
    
11. ISHIKAWA T, Okai M, Mochizuki E, Uchiyama T, et al
    Bacillus Calmette-Guerin (BCG) Infections at High Frequency in Both AR-CGD and X-CGD Patients Following BCG Vaccination.
    Clin Infect Dis. 2021;73:e2538-e2544.
    PubMed         Abstract available
    
    
12. THOMPSON RR, Kong CL, Porco TC, Kim E, et al
    Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.
    Clin Infect Dis. 2021;73:e3210-e3217.
    PubMed         Abstract available
    
    
13. MIELLET WR, van Veldhuizen J, Nicolaie MA, Mariman R, et al
    Influenza-like Illness Exacerbates Pneumococcal Carriage in Older Adults.
    Clin Infect Dis. 2021;73:e2680-e2689.
    PubMed         Abstract available
    
    
14. BERENSON AB, Hirth JM, Chang M
    Prevalence of Genital Human Papillomavirus by Age and Race/Ethnicity Among Males.
    Clin Infect Dis. 2021;73:1625-1633.
    PubMed         Abstract available
    
    
15. BROWN NE, Blain AE, Burzlaff K, Harrison LH, et al
    Racial Disparities in Invasive Haemophilus influenzae Disease-United States, 2008-2017.
    Clin Infect Dis. 2021;73:1617-1624.
    PubMed         Abstract available
    
    

    
    J Immunol

16. JEEWANDARA C, Guruge D, Pushpakumara PD, Kamaladasa A, et al
    Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
    J Immunol. 2021 Nov 8. pii: jimmunol.2100762. doi: 10.4049/jimmunol.2100762.
    PubMed         Abstract available
    
    

    
    J Infect

17. GIMENEZ E, Alberola J, Torres I, Albert E, et al
    Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2021 Nov 2. pii: S0163-4453(21)00542.
    PubMed        
    
    

    
    J Infect Dis

18. STOCKDALE AJ, Meiring JE, Shawa IT, Thindwa D, et al
    Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi.
    J Infect Dis. 2021 Nov 9. pii: 6424415. doi: 10.1093.
    PubMed         Abstract available
    
    
19. JOHNSON S, Martinez CI, Tedjakusuma SN, Peinovich N, et al
    Oral vaccination protects against SARS-CoV-2 in a Syrian hamster challenge model.
    J Infect Dis. 2021 Nov 10. pii: 6425228. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    JAMA

20. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.
    PubMed        
    
    
21. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.
    PubMed        
    
    
22. ABBASI J
    "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
    JAMA. 2021;326:1784.
    PubMed        
    
    
23. 
    Routine Smallpox Vaccination.
    JAMA. 2021;326:1876.
    PubMed        
    
    

    
    Lancet

24. FALCARO M, Castanon A, Ndlela B, Checchi M, et al
    The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02178.
    PubMed         Abstract available
    
    
25. MCNAMARA LA, Wiegand RE, Burke RM, Sharma AJ, et al
    Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02226.
    PubMed         Abstract available
    
    
26. ORTIZ JR, Neuzil KM
    The value of vaccine programme impact monitoring during the COVID-19 pandemic.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02322.
    PubMed        
    
    
27. BARDA N, Dagan N, Cohen C, Hernan MA, et al
    Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
    Lancet. 2021 Oct 29. pii: S0140-6736(21)02249.
    PubMed         Abstract available
    
    
28. GRANGE Z, Buelo A, Sullivan C, Moore E, et al
    Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland.
    Lancet. 2021 Oct 28. pii: S0140-6736(21)02316.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

29. WOODWORTH KR, Moulia D, Collins JP, Hadler SC, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1579-1583.
    PubMed         Abstract available
    
    
30. 
    QuickStats: Percentage* of Adults Aged >/=18 Years Who Received an Influenza Vaccination in the Past 12 Months,(dagger) by Sex and Age Group - National Health Interview Survey,( section sign) United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1586.
    PubMed        
    
    
31. ROMAN PC, Kirtland K, Zell ER, Jones-Jack N, et al
    Influenza Vaccinations During the COVID-19 Pandemic - 11 U.S. Jurisdictions, September-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1575-1578.
    PubMed         Abstract available
    
    

    
    N Engl J Med

32. WALTER EB, Talaat KR, Sabharwal C, Gurtman A, et al
    Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2021 Nov 9. doi: 10.1056/NEJMoa2116298.
    PubMed         Abstract available
    
    
33. TORGOVNICK J
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    PubMed        
    
    
34. LINSENMEYER K, Gupta K, Charness ME
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    PubMed        
    
    
35. EMANI VR, Reddy R, Goswami S
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    PubMed        
    
    
36. LOPEZ BERNAL J, Gower C, Andrews N
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    PubMed        
    
    
37. RUBIN EJ, Baden LR, Grinsztejn B, Morrissey S, et al
    Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children.
    N Engl J Med. 2021;385:e79.
    PubMed        
    
    

    
    Pediatrics

38. 
    COVID-19 Vaccines in Children and Adolescents.
    Pediatrics. 2021 Nov 5. pii: peds.2021-054332. doi: 10.1542/peds.2021-054332.
    PubMed        
    
    

    
    PLoS One

39. MBULAWA ZZA, Somdyala NI, Mabunda SA, Williamson AL, et al
    High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa.
    PLoS One. 2021;16:e0253074.
    PubMed         Abstract available
    
    
40. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common gammac cytokines in elderly individuals.
    PLoS One. 2021;16:e0258743.
    PubMed         Abstract available
    
    
41. WISMANS A, Thurik R, Baptista R, Dejardin M, et al
    Correction: Psychological characteristics and the mediating role of the 5C Model in explaining students' COVID-19 vaccination intention.
    PLoS One. 2021;16:e0259922.
    PubMed         Abstract available
    
    
42. HEINE F, Wolters E
    Using moral foundations in government communication to reduce vaccine hesitancy.
    PLoS One. 2021;16:e0259435.
    PubMed         Abstract available
    
    
43. GRAY AN, Martin-Blais R, Tobin NH, Wang Y, et al
    Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection.
    PLoS One. 2021;16:e0259703.
    PubMed         Abstract available
    
    
44. GOMES DE MACEDO BACURAU A, Sato APS, Francisco PMSB
    Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2021;16:e0259640.
    PubMed         Abstract available
    
    
45. KISAKA S, Makumbi FE, Majalija S, Kagaha A, et al
    "As long as the patient tells you it was a dog that bit him, why do you need to know more?" A qualitative study of how healthcare workers apply clinical guidelines to treat dog bite injuries in selected hospitals in Uganda.
    PLoS One. 2021;16:e0254650.
    PubMed         Abstract available
    
    

    
    Vaccine

46. GARCIA-GRIMSHAW M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al
    Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
    Vaccine. 2021 Oct 29. pii: S0264-410X(21)01391.
    PubMed         Abstract available
    
    
47. MALTEZOU HC, Panagopoulos P, Sourri F, Giannouchos TV, et al
    COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01387.
    PubMed         Abstract available
    
    
48. PIERRON A, Bozon F, Berceanu A, Fontan J, et al
    Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?
    Vaccine. 2021 Nov 2. pii: S0264-410X(21)01369.
    PubMed         Abstract available
    
    
49. MIYA TV, Groome MJ, de Assis Rosa D
    TLR genetic variation is associated with Rotavirus-specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine.
    Vaccine. 2021 Nov 2. pii: S0264-410X(21)01384.
    PubMed         Abstract available
    
    
50. VASUDEVAN L, Ostermann J, Wang Y, Harrison SE, et al
    Predictors of HPV vaccination in the southern US: A survey of caregivers from 13 states.
    Vaccine. 2021 Nov 3. pii: S0264-410X(21)01356.
    PubMed         Abstract available
    
    
51. SANZ-ROJO S, Jimenez-Garcia R, Lopez-de-Andres A, de Miguel-Diez J, et al
    Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020.
    Vaccine. 2021 Nov 3. pii: S0264-410X(21)01392.
    PubMed         Abstract available
    
    
52. GORDON SF, Clothier HJ, Morgan H, Buttery JP, et al
    Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
    Vaccine. 2021 Oct 29. pii: S0264-410X(21)01350.
    PubMed         Abstract available
    
    
53. CHEN AT, Stacey HD, Marzok A, Singh P, et al
    Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies.
    Vaccine. 2021 Oct 18. pii: S0264-410X(21)01341.
    PubMed         Abstract available
    
    
54. MAKOVITZKI A, Lerer E, Kafri Y, Adar Y, et al
    Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01376.
    PubMed         Abstract available
    
    
55. OLANIPEKUN T, Abe T, Effoe V, Westney G, et al
    Changes in COVID-19 vaccine acceptance rate among recovered critically Ill patients: A 12-month follow-up study.
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01324.
    PubMed         Abstract available
    
    
56. VILLANUEVA-UY MET, Lam HY, Aldaba JG, Uy TMZ, et al
    Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
    Vaccine. 2021 Nov 6. pii: S0264-410X(21)01290.
    PubMed         Abstract available
    
    
57. CUEVAS-JUAREZ E, Pando-Robles V, Palomares LA
    Flavivirus vaccines: Virus-like particles and single-round infectious particles as promising alternatives.
    Vaccine. 2021 Nov 6. pii: S0264-410X(21)01383.
    PubMed         Abstract available
    
    
58. LIU H, Zhou C, An J, Song Y, et al
    Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01399.
    PubMed         Abstract available
    
    
59. CASSONE A, Cauda R
    Multicomponent vaccines to fight SARS-CoV-2 variants of concern.
    Vaccine. 2021 Nov 1. pii: S0264-410X(21)01402.
    PubMed        
    
    
60. DE HAAS TDJ, Yeung KHT, Hutubessy R, van der Putten IM, et al
    Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
    Vaccine. 2021;39:6762-6780.
    PubMed         Abstract available
    
    
61. WANG J, Wagner AL, Chen Y, Jaime E, et al
    Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01340.
    PubMed         Abstract available
    
    

    
    Virology

62. AHMED SM, Nasr MA, Elshenawy SE, Hussein AE, et al
    BCG vaccination and the risk of COVID 19: A possible correlation.
    Virology. 2021;565:73-81.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: